These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 24825748

  • 1. GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer.
    Labrie F.
    Endocr Relat Cancer; 2014 Aug; 21(4):R301-17. PubMed ID: 24825748
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is dehydroepiandrosterone a hormone?
    Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C.
    J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
    [Abstract] [Full Text] [Related]

  • 6. Combined androgen blockade for prostate cancer: review of efficacy, safety and cost-effectiveness.
    Akaza H.
    Cancer Sci; 2011 Jan; 102(1):51-6. PubMed ID: 21091846
    [Abstract] [Full Text] [Related]

  • 7. Combined blockade of testicular and locally made androgens in prostate cancer: a highly significant medical progress based upon intracrinology.
    Labrie F.
    J Steroid Biochem Mol Biol; 2015 Jan; 145():144-56. PubMed ID: 24925260
    [Abstract] [Full Text] [Related]

  • 8. Endocrine treatment of prostate cancer.
    Tammela T.
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [Abstract] [Full Text] [Related]

  • 9. Overview of enzyme inhibitors and anti-androgens in prostatic cancer.
    Geller J.
    J Androl; 1991 Nov; 12(6):364-71. PubMed ID: 1769904
    [Abstract] [Full Text] [Related]

  • 10. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T, Fujii Y, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Masuda H, Kawakami S, Kihara K.
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [Abstract] [Full Text] [Related]

  • 11. Endocrine therapy: where do we stand and where are we going?
    Schröder FH.
    Cancer Surv; 1991 Oct; 11():177-94. PubMed ID: 1841751
    [Abstract] [Full Text] [Related]

  • 12. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP.
    J Pharmacol; 1983 Oct; 14 Suppl 3():117-35. PubMed ID: 6423907
    [Abstract] [Full Text] [Related]

  • 13. [Monotherapy versus combined androgen blockade for advanced/metastatic prostate cancer].
    Iida K.
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2553-7. PubMed ID: 22189220
    [Abstract] [Full Text] [Related]

  • 14. Endocrine therapy for prostate cancer.
    Labrie F.
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Controversies in the management of advanced prostate cancer.
    Tyrrell CJ.
    Br J Cancer; 1999 Jan; 79(1):146-55. PubMed ID: 10408706
    [Abstract] [Full Text] [Related]

  • 17. The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.
    Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M.
    J Urol; 2005 Aug; 174(2):547-52; discussion 552. PubMed ID: 16006889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endocrine prevention and treatment of prostate cancer.
    Tammela TL.
    Mol Cell Endocrinol; 2012 Sep 05; 360(1-2):59-67. PubMed ID: 22465099
    [Abstract] [Full Text] [Related]

  • 20. Major impact of hormonal therapy in localized prostate cancer--death can already be an exception.
    Labrie F, Cusan L, Gomez J, Luu-The V, Candas B, Bélanger A, Labrie C.
    J Steroid Biochem Mol Biol; 2004 Dec 05; 92(5):327-44. PubMed ID: 15698538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.